Additional file 1 of Efficacy and safety of avacopan in antineutrophil cytoplasmic autoantibody-associated vasculitis: a retrospective cohort study in Japan
Supplementary Material 1 Supplemental Figure 1. Timeline of individual immunosuppressive treatment, including prednisolone, and the timing of avacopan initiation for all 21 patients (avacopan continuation group (n = 12, patients 1–12) and discontinuation group (n = 9, patients 13–21))
Institutions
- Aichi Medical University (JP)
- Nagoya University Hospital (JP)
Publication Details
- Journal
- Figshare
- Published
- 2025-01-01
- DOI
- https://doi.org/10.6084/m9.figshare.28261140.v1
- Primary Topic
- Vasculitis and related conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00